-$0.23 Earnings Per Share Expected for Cardiff Oncology, Inc. (NASDAQ:CRDF) This Quarter

Wall Street brokerages expect Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Rating) to report earnings of ($0.23) per share for the current quarter, Zacks reports. Two analysts have issued estimates for Cardiff Oncology’s earnings, with the highest EPS estimate coming in at ($0.21) and the lowest estimate coming in at ($0.24). Cardiff Oncology reported earnings of […]

Related Keywords

California ,United States ,William Blair ,Cardiff Oncology Inc ,Elkhorn Partners Limited Partnership ,Zacks Investment Research ,Manufacturers Life Insurance Company ,Nasdaq ,Invesco Ltd ,Cardiff Oncology Company Profile Get Rating ,Maxim Group ,Citigroup Inc ,Wall Street ,Cardiff Oncology ,Get Rating ,Investment Research ,Partners Limited Partnership ,Oncology Company Profile ,Polo Like Kinase ,Nasdaq Crdf ,Acrdf ,Medical ,Ratings ,Consensus ,